Literature DB >> 23578839

Impaired fear extinction learning in adult heterozygous BDNF knock-out mice.

Laura Psotta1, Volkmar Lessmann, Thomas Endres.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a crucial regulator of neuroplasticity, which underlies learning and memory processes in different brain areas. To investigate the role of BDNF in the extinction of amygdala-dependent cued fear memories, we analyzed fear extinction learning in heterozygous BDNF knock-out mice, which possess a reduction of endogenous BDNF protein levels to ~50% of wild-type animals. Since BDNF expression has been shown to decline with aging of animals, we tested the performance in extinction learning of these mice at 2 months (young adults) and 7 months (older adults) of age. The present study shows that older adult heterozygous BDNF knock-out mice, which have a chronic 50% lack of BDNF, also possess a deficit in the acquisition of extinction memory, while extinction learning remains unaffected in young adult heterozygous BDNF knock-out mice. This deficit in extinction learning is accompanied by a reduction of BDNF protein in the hippocampus, amygdala and the prefrontal cortex.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578839     DOI: 10.1016/j.nlm.2013.03.003

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  25 in total

1.  Mice lacking TrkB in parvalbumin-positive cells exhibit sexually dimorphic behavioral phenotypes.

Authors:  Elizabeth K Lucas; Anita Jegarl; Roger L Clem
Journal:  Behav Brain Res       Date:  2014-08-12       Impact factor: 3.332

Review 2.  On the resilience of remote traumatic memories against exposure therapy-mediated attenuation.

Authors:  Li-Huei Tsai; Johannes Gräff
Journal:  EMBO Rep       Date:  2014-07-15       Impact factor: 8.807

Review 3.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

Review 4.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 5.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 6.  Systematic Review of the Clinical Application of Exposure Techniques to Community-Dwelling Older Adults with Anxiety.

Authors:  Nimali Jayasinghe; Lucy Finkelstein-Fox; Lili Sar-Graycar; Mary-Jane Ojie; Martha L Bruce; JoAnn Difede
Journal:  Clin Gerontol       Date:  2017-02-06       Impact factor: 2.619

7.  Sign-tracking to an appetitive cue predicts incubation of conditioned fear in rats.

Authors:  Jonathan D Morrow; Benjamin T Saunders; Stephen Maren; Terry E Robinson
Journal:  Behav Brain Res       Date:  2014-04-18       Impact factor: 3.332

8.  BDNFval66met affects neural activation pattern during fear conditioning and 24 h delayed fear recall.

Authors:  Tina B Lonsdorf; Armita Golkar; Kara M Lindström; Jan Haaker; Arne Öhman; Martin Schalling; Martin Ingvar
Journal:  Soc Cogn Affect Neurosci       Date:  2014-08-07       Impact factor: 3.436

9.  Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder.

Authors:  Seid Muhie; Aarti Gautam; James Meyerhoff; Nabarun Chakraborty; Rasha Hammamieh; Marti Jett
Journal:  Mol Brain       Date:  2015-02-28       Impact factor: 4.041

Review 10.  Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders.

Authors:  Michael Notaras; Maarten van den Buuse
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.